Stock SLRN ACELYRIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Acelyrin, Inc.

Equities

SLRN

US00445A1007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
4.1 USD -0.49% Intraday chart for Acelyrin, Inc. -0.73% -45.04%
May. 22 HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating MT
May. 14 Acelyrin, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ACELYRIN, INC. Stock Acelyrin, Inc.
 408M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. SLRN Stock
  4. Charts Acelyrin, Inc.
  5. Sector Chart